References
- Delivery statistics of the National Corporation of Swedish Pharmacies. Stockholm 1990
- Svensson J, Blombäck M, Kockum C. Hög frekvens av blödningskomplikationer vid antikoagula-tionsbehandling (High frequency of bleeding complications during anticoagulant treatment). Läkartidningen 1985; 82: 1240–4, in Swedish
- Kumar S, Haigh J RM, Rhodes L E, Peaker S, Davies J A, Roberts B E, et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 1989; 62: 729–32
- Duxbury B McD. Therapeutic control of anticoagulant treatment. BMJ 1982; 284: 702–4
- Harries A D, Birtwell A J, Jones D B. Anticoagulant control. Lancet 1981; i: 1320
- Petitti D B, Strom B L, Melmon K L. Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage. Am J Med 1986; 81: 255–9
- Launbjerg J, Egeblad H, Heaf J, Nielsen N H, Fugleholm A M, Ladefoged K. Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients. J Int Med 1991; 229: 351–5
- Levine M N, Raskob G, Hirsh J. Risk of haemorrhage associated with long term anticoagulant therapy. Drugs 1985; 30: 444–60
- Läkemedelsverket. Swedish medical products agency 1992; 3: 7–55, in Swedish
- Petersen P, Boysen G, Godtfredsen J, Andersen E D, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thrombo-embolic complications in chronic atrial fibrillation. the Copenhagen AFASAK study. Lancet 1989; i: 175–9
- Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation SPAF study: final results. Circulation 1991; 84: 527–39
- The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators BAATAF. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505–11
- Jonas S. Anticoagulant therapy in cerebrovascular disease: review and meta-analysis. Stroke 1988; 19: 1043–8
- McInnes G T, Prentice A G. Documentation at an anticoagulant clinic. Proceedings of the 4th Annual WAMI Meeting Politiers: Imp SIPAP. 1981, F P Begon. 306–10
- Schulman S, Lockner D. Relationship between thromboembolic complications and intensity of treatment during long-term prophylaxis with oral anticoagulants following DVT. Thromb Haemost 1985; 53: 137–40
- Schulman S, Stigendal L, Jansson J H, Brohult J. Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants. Acta Med Scand 1988; 224: 425–30
- Lundström T, Rydén L. Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis. J Int Med 1989; 224: 137–42
- Levine M N. Hemorrhagic complications of long-term anticoagulant therapy. Chest 1989; 95(suppl.)26S–36S
- Andersson P, Waem U. Behandling med anticoagulantia (Treatment with anticoagulants). Opuscula Medica 1981; 26: 131–3, in Swedish